Home
Click for links to local companies
About Us Our Products Your Health Innovation Media Careers Business
 Headlines and current announcements
Intended Sale
Akzo Nobel has announced that it received an offer for the purchase of its wholly owned subsidiary Organon BioSciences N.V. (OBS) from Schering-Plough.
Asenapine
October 17, 2007 - New data show that asenapine – a psychopharmacologic agent being developed by Organon – is effective in treating acute manic episodes associated with Bipolar I Disorder.
Sugammadex
October 16, 2007 - New trial results of sugammadex - the novel selective relaxant binding agent (SRBA) being developed by Organon - were presented at the 2007 annual meeting of the American Society of Anesthesiologists (ASA).
Presentation of Awards
September 27, 2007 - The NVF-Organon Pharmacology Award and the Ariëns Award 2007 will be presented during the Dutch Pharmacology Society’s annual pharmacology days in Lunteren, the Netherlands.
Privacy Statement | Terms of Use | © 2007 Organon | Contact Us